Lv1
70 积分 2025-08-24 加入
BGB-45035, a selective IRAK4 CDAC, demonstrated fast IRAK4 degradation and strong signaling inhibition, and superior efficacy in preclinical disease models 2529
3天前
已完结
[Clinical practice guideline for molecular pathology in colorectal cancer (2025 version)]
1个月前
已完结
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis
2个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
8个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
8个月前
已完结